"Study of Theranos Medical Tests Finds Irregular Results"
Finger blood tests from Theranos, the medical start-up, produced more irregular results than conventional tests offered by the nation’s two largest clinical laboratories, researchers reported Monday in the first published independent assessment of the company’s tests. “There’s actually pretty widespread variability in these clinical measures, even between the reference labs,” said Eric Schadt, PhD, the founding director of the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai and an author of the report. “But Theranos was more outside of range and outside of range in ways that would impact clinical decision-making.” Learn more.
Sanofi, Sema4, Mount Sinai Collaborate on Largest Asthma Study of Its Kind
Dec 04, 2018 View All Press ReleasesSystems Biology Research Study Reveals Benefits of Vacation and Meditation
Aug 30, 2016 View All Press Releases